Table 2.

Tissue expression and Gene Ontology (GO) pathway analysis of selected lncRNA genes containing pG4, piM, or pRL structures

Gene symbolEnsembl Gene IDPredicted structure type(s)Tissue(s)Main pathway(s) identified
MIATENSG00000225783G4, iM, RLBrain, pituitaryCell fate specification/commitment, differentiation
H19ENSG00000130600G4, iM, RLPlacentaMetabolism of purines, oxidative stress, ATP metabolism, hepatocyte apoptosis
ELFN2 (lncRNA variant)ENSG00000243902G4, iM, RLBrain, testisRegulation of protein dephosphorylation
HOTAIRENSG00000228630G4Testis, skinEpigenetic silencing of gene expression
MYCNOSENSG00000233718G4, iMTestisNegative regulation of protein phosphorylation
LINC01783ENSG00000233421G4, RLTestisMolecular adaptor activity—targets miRNA to promote cancer-associated pathways
LINC03126ENSG00000228549G4, RLTestisMolecular adaptor activity
SNAP25-AS1ENSG00000227906iMBrain, pituitarySRP-dependent cotranslational protein targeting to membrane (endoplasmic reticulum), signal sequence recognition
CDKN2B-AS1ENSG00000240498iMColon, small intestineEpigenetic silencing of gene expression
GJD2-DTENSG00000250007iM, RLBrain, heart, pituitarySRP-dependent cotranslational protein targeting to membrane (endoplasmic reticulum), signal sequence recognition
TAB2 (lncRNA variant)ENSG00000228408RLBrainMYD88-dependent TLR signaling pathway, JNK cascade, response to IL1 regulation of I kappa B kinase/NF-kB signaling, MAPK signaling pathway